The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight
Gespeichert in:
| Veröffentlicht in: | Diabetes, obesity & metabolism obesity & metabolism, 2007-01, Vol.9 (1), p.132-133 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 133 |
|---|---|
| container_issue | 1 |
| container_start_page | 132 |
| container_title | Diabetes, obesity & metabolism |
| container_volume | 9 |
| creator | Schöndorf, T. Forst, T. Hohberg, C. Pahler, S. Link, C. Roth, W. Pfützner, A. Lübben, G. Link, C. Pfützner, A. |
| description | |
| doi_str_mv | 10.1111/j.1463-1326.2006.00582.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68388418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68388418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4042-3c8064b2ec4dfd919fed20ae4243f6c351fe5dbca473ac033d94bf1a049847463</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSMEoj_wCsgrdgl27EkcxAYV2kYqLSqDWFqOfTPjIROntsNMeAieGU8zKlu88ZXvd651z0kSRHBG4nm3yQgraEpoXmQ5xkWG8YLn2f5ZcvrUeP5Y5ymvcH6SnHm_wRgzysuXyQkpSVWVFJ8mf5ZrQPV9_Q3VdY18GPX0Hg3GrjoT5G_bAzLbwdlf4NEWgmxsZxRStg_Odkj2GjWdtRoNDrwfXaR7NMhgoA8e7UxYozANgHKkjWwgwPxoxxBB5UB6069QY_WEdmBW6_AqedHKzsPr432efL_8vLy4Tm_uruqLjzepYpjlKVUcF6zJQTHd6opULegcS2A5o22h6IK0sNCNkqykUmFKdcWalkjMKs7K6NB58naeG3d7GMEHsTVeQdfJHuzoRcEp54zwCPIZVM5676AVgzNb6SZBsDhkITbiYLk4WC4OWYjHLMQ-St8c_xibLeh_wqP5EfgwAzvTwfTfg8Wnuy-xiPJ0lhsfYP8kl-6nKEpaLsSP2ytxWTJ2v8RfxS39CxkYqUk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68388418</pqid></control><display><type>article</type><title>The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schöndorf, T. ; Forst, T. ; Hohberg, C. ; Pahler, S. ; Link, C. ; Roth, W. ; Pfützner, A. ; Lübben, G. ; Link, C. ; Pfützner, A.</creator><creatorcontrib>Schöndorf, T. ; Forst, T. ; Hohberg, C. ; Pahler, S. ; Link, C. ; Roth, W. ; Pfützner, A. ; Lübben, G. ; Link, C. ; Pfützner, A.</creatorcontrib><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/j.1463-1326.2006.00582.x</identifier><identifier>PMID: 17199730</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Body Weight - drug effects ; Diabetes Mellitus, Type 2 - drug therapy ; Female ; Humans ; Hypertension - drug therapy ; Hypoglycemic Agents - therapeutic use ; Male ; Metabolic Syndrome - drug therapy ; Middle Aged ; Thiazolidinediones - therapeutic use</subject><ispartof>Diabetes, obesity & metabolism, 2007-01, Vol.9 (1), p.132-133</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4042-3c8064b2ec4dfd919fed20ae4243f6c351fe5dbca473ac033d94bf1a049847463</citedby><cites>FETCH-LOGICAL-c4042-3c8064b2ec4dfd919fed20ae4243f6c351fe5dbca473ac033d94bf1a049847463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1463-1326.2006.00582.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1463-1326.2006.00582.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17199730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schöndorf, T.</creatorcontrib><creatorcontrib>Forst, T.</creatorcontrib><creatorcontrib>Hohberg, C.</creatorcontrib><creatorcontrib>Pahler, S.</creatorcontrib><creatorcontrib>Link, C.</creatorcontrib><creatorcontrib>Roth, W.</creatorcontrib><creatorcontrib>Pfützner, A.</creatorcontrib><creatorcontrib>Lübben, G.</creatorcontrib><creatorcontrib>Link, C.</creatorcontrib><creatorcontrib>Pfützner, A.</creatorcontrib><title>The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight</title><title>Diabetes, obesity & metabolism</title><addtitle>Diabetes Obes Metab</addtitle><subject>Aged</subject><subject>Body Weight - drug effects</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Metabolic Syndrome - drug therapy</subject><subject>Middle Aged</subject><subject>Thiazolidinediones - therapeutic use</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhSMEoj_wCsgrdgl27EkcxAYV2kYqLSqDWFqOfTPjIROntsNMeAieGU8zKlu88ZXvd651z0kSRHBG4nm3yQgraEpoXmQ5xkWG8YLn2f5ZcvrUeP5Y5ymvcH6SnHm_wRgzysuXyQkpSVWVFJ8mf5ZrQPV9_Q3VdY18GPX0Hg3GrjoT5G_bAzLbwdlf4NEWgmxsZxRStg_Odkj2GjWdtRoNDrwfXaR7NMhgoA8e7UxYozANgHKkjWwgwPxoxxBB5UB6069QY_WEdmBW6_AqedHKzsPr432efL_8vLy4Tm_uruqLjzepYpjlKVUcF6zJQTHd6opULegcS2A5o22h6IK0sNCNkqykUmFKdcWalkjMKs7K6NB58naeG3d7GMEHsTVeQdfJHuzoRcEp54zwCPIZVM5676AVgzNb6SZBsDhkITbiYLk4WC4OWYjHLMQ-St8c_xibLeh_wqP5EfgwAzvTwfTfg8Wnuy-xiPJ0lhsfYP8kl-6nKEpaLsSP2ytxWTJ2v8RfxS39CxkYqUk</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Schöndorf, T.</creator><creator>Forst, T.</creator><creator>Hohberg, C.</creator><creator>Pahler, S.</creator><creator>Link, C.</creator><creator>Roth, W.</creator><creator>Pfützner, A.</creator><creator>Lübben, G.</creator><creator>Link, C.</creator><creator>Pfützner, A.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200701</creationdate><title>The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight</title><author>Schöndorf, T. ; Forst, T. ; Hohberg, C. ; Pahler, S. ; Link, C. ; Roth, W. ; Pfützner, A. ; Lübben, G. ; Link, C. ; Pfützner, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4042-3c8064b2ec4dfd919fed20ae4243f6c351fe5dbca473ac033d94bf1a049847463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Body Weight - drug effects</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Metabolic Syndrome - drug therapy</topic><topic>Middle Aged</topic><topic>Thiazolidinediones - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schöndorf, T.</creatorcontrib><creatorcontrib>Forst, T.</creatorcontrib><creatorcontrib>Hohberg, C.</creatorcontrib><creatorcontrib>Pahler, S.</creatorcontrib><creatorcontrib>Link, C.</creatorcontrib><creatorcontrib>Roth, W.</creatorcontrib><creatorcontrib>Pfützner, A.</creatorcontrib><creatorcontrib>Lübben, G.</creatorcontrib><creatorcontrib>Link, C.</creatorcontrib><creatorcontrib>Pfützner, A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schöndorf, T.</au><au>Forst, T.</au><au>Hohberg, C.</au><au>Pahler, S.</au><au>Link, C.</au><au>Roth, W.</au><au>Pfützner, A.</au><au>Lübben, G.</au><au>Link, C.</au><au>Pfützner, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight</atitle><jtitle>Diabetes, obesity & metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2007-01</date><risdate>2007</risdate><volume>9</volume><issue>1</issue><spage>132</spage><epage>133</epage><pages>132-133</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17199730</pmid><doi>10.1111/j.1463-1326.2006.00582.x</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1462-8902 |
| ispartof | Diabetes, obesity & metabolism, 2007-01, Vol.9 (1), p.132-133 |
| issn | 1462-8902 1463-1326 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68388418 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Aged Body Weight - drug effects Diabetes Mellitus, Type 2 - drug therapy Female Humans Hypertension - drug therapy Hypoglycemic Agents - therapeutic use Male Metabolic Syndrome - drug therapy Middle Aged Thiazolidinediones - therapeutic use |
| title | The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T02%3A44%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20IRIS%20III%20study:%20pioglitazone%20improves%20metabolic%20control%20and%20blood%20pressure%20in%20patients%20with%20type%202%20diabetes%20without%20increasing%20body%20weight&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Sch%C3%B6ndorf,%20T.&rft.date=2007-01&rft.volume=9&rft.issue=1&rft.spage=132&rft.epage=133&rft.pages=132-133&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/j.1463-1326.2006.00582.x&rft_dat=%3Cproquest_cross%3E68388418%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68388418&rft_id=info:pmid/17199730&rfr_iscdi=true |